Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie A Sims

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Bone|April 5, 2008
Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized ratsJulie F McManus, Rachel A Davey, Helen E Maclean, et al.
Cancer Research|June 3, 2005
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell lineJohn T Price, Julian M W Quinn, Natalie A Sims, et al.
Development (Cambridge, England)|January 13, 2016
Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossificationStephen Tonna, Ingrid J Poulton, Farzin Taykar, et al.
Blood|August 18, 2010
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCsIngrid G Winkler, Natalie A Sims, Allison R Pettit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 21, 2012
EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repairAgnieszka Arthur, Romana A Panagopoulos, Lachlan Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaAgatha Labrinidis, Peter Diamond, Sally Martin, et al.
The Journal of Clinical Investigation|March 25, 2009
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceMaya Kansara, Michael Tsang, Laurent Kodjabachian, et al.
Computers in Biology and Medicine|July 6, 2025
Bridging spectroscopy and advanced molecular orientation analysis with new 4＋ angle polarization toolbox in QuasarCallum Gassner, Jitraporn Vongsvivut, Meguya Ryu, et al.
The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Bone|April 5, 2008
Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized ratsJulie F McManus, Rachel A Davey, Helen E Maclean, et al.
Cancer Research|June 3, 2005
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell lineJohn T Price, Julian M W Quinn, Natalie A Sims, et al.
Development (Cambridge, England)|January 13, 2016
Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossificationStephen Tonna, Ingrid J Poulton, Farzin Taykar, et al.
Blood|August 18, 2010
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCsIngrid G Winkler, Natalie A Sims, Allison R Pettit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 21, 2012
EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repairAgnieszka Arthur, Romana A Panagopoulos, Lachlan Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaAgatha Labrinidis, Peter Diamond, Sally Martin, et al.
The Journal of Clinical Investigation|March 25, 2009
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceMaya Kansara, Michael Tsang, Laurent Kodjabachian, et al.
Computers in Biology and Medicine|July 6, 2025
Bridging spectroscopy and advanced molecular orientation analysis with new 4＋ angle polarization toolbox in QuasarCallum Gassner, Jitraporn Vongsvivut, Meguya Ryu, et al.
The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.
Pageof 18